First methyl-preserving DNA amplification technology enabling accurate epigenetic analysis for disease detection, epi-therapeutics, and biopharma research.
EpiAmp is Epinoma's proprietary methyl-preserving amplification technology that preserves DNA methylation during analysis, overcoming the sequence conversion and degradation limitations of current approaches. It enables deep insights into the epigenome for disease detection (early cancer and neurodegenerative disease markers), precision epigenetic medicine through programmable epigenetic modulation, and biopharma acceleration through comparison of healthy versus diseased methylation states for drug development and patient stratification. EpiAmp is a product of Epinoma.